Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Mesothelioma |
| Start Date: | May 1, 1997 |
| Phase: | Phase III |
| Status: | Active, not recruiting |
| NCT ID: | NCT00003034 |
| Study Type: | Interventional |
| Intervention: | Drug: doxorubicin hydrochloride|Drug: ranpirnase |
| Study Design: | Allocation: Randomized|Control: Active Control|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Alfacell |
| Ages: | Adult|Senior |
| Enrollment: | 300 |
| Funded By: | Industry |
| First Received: | November 1, 1999 |
| End Date: | |
| Last Updated: | April 26, 2009 |
| Last Verified: | October 1, 2007 |